Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subversion of Lipopolysaccharide Signaling in Gingival Keratinocytes via MCPIP-1 Degradation as a Novel Pathogenic Strategy of Inflammophilic Pathobionts. | mBio | 2021 | 34182783 | PubTator, text mining | PubMed |
| Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma. | J Med Chem | 2021 | 34181850 | PubTator, text mining | PubMed |
| Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. | Front Immunol | 2021 | 34177947 | PubTator, text mining | PubMed |
| Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. | J Exp Clin Cancer Res | 2021 | 34174926 | PubTator, text mining | PubMed |
| Immunology of Lynch Syndrome. | Curr Oncol Rep | 2021 | 34125344 | PubTator, text mining | PubMed |
| Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies. | Inorg Chem | 2021 | 34115482 | PubTator, text mining | PubMed |
| Prognostic molecular biomarkers in diffuse large B-cell lymphoma in the rituximab era and their therapeutic implications. | Ther Adv Hematol | 2021 | 34104369 | PubTator, text mining | PubMed |
| Assessing the efficacy of a stepped-care group treatment programme for borderline personality disorder: study protocol for a pragmatic trial. | Trials | 2021 | 34099033 | PubTator, text mining | PubMed |
| CD34+ derived macrophage and dendritic cells display differential responses to paraquat. | Toxicol In Vitro | 2021 | 34097952 | PubTator, text mining | PubMed |
| ARL15 modulates magnesium homeostasis through N-glycosylation of CNNMs. | Cell Mol Life Sci | 2021 | 34089346 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions. | Cancers (Basel) | 2021 | 34071918 | PubTator, text mining | PubMed |
| From Benign Inflammatory Dermatosis to Cutaneous Lymphoma. DNA Copy Number Imbalances in Mycosis Fungoides versus Large Plaque Parapsoriasis. | Medicina (Kaunas) | 2021 | 34063545 | PubTator, text mining | PubMed |
| Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs). | J Immunother Cancer | 2021 | 34049932 | PubTator, text mining | PubMed |
| Investigation of the hepatic development in the coculture of hiPSCs-derived LSECs and HLCs in a fluidic microenvironment. | APL Bioeng | 2021 | 34027283 | PubTator, text mining | PubMed |
| Extracellular vesicles in urological malignancies. | Biochim Biophys Acta Rev Cancer | 2021 | 34019971 | PubTator, text mining | PubMed |
| Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge. | Clin Exp Immunol | 2021 | 34008169 | PubTator, text mining | PubMed |
| The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases. | Genes Dis | 2021 | 33997176 | PubTator, text mining | PubMed |
| Relapsed Primary Central Nervous System Lymphoma: Current Advances. | Front Oncol | 2021 | 33996566 | PubTator, text mining | PubMed |
| The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. | Front Immunol | 2021 | 33995383 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=43